Home About Us Contact Us

 

Table of Content Volume 14 Issue 3 - June 2020


A comparative study of lipid profile in IHD patients and healthy controls

 

Pandit Kishanrao Deshmukh1, Manohar Shankarrao Chavan2*

 

1Assistant Professor, 2Associate Professor, Department of General Medicine, Mahavir Institute of Medical Sciences(MIMS), Shivareddypet(V), Vikarabad, Telangana, INDIA.

 

Abstract              Background: The World Health Organisation (WHO) has drawn attention to the fact that IHD is our modern "epidemic" that affects populations. Hypercholesterolaemia and hypertriglyceridaemia are considered the independent risk factors for Ischemic heart disease. Aim and objective: To compare the lipid profile of Ischaemic Heart Disease patients and matched healthy controls Methodology: Present study was a case control study carried out in patients diagnosed as Ischaemic Heart Disease patients and healthy controls. Data was collected with pretested questionnaire. Data included demographic characters, clinical history (significant past or family history) of the patients and lipid profile. Fasting and postprandial Blood cholesterol, triglyceride, high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, very low density lipoprotein (VLDL) cholesterol were estimated in both cases and controls. Results: Fasting levels of triglycerides (170.65 mg/dl), serum VLDL(34.64 mg/dl) and total cholesterol(187.5 mg/dl) in patients of IHD are significantly higher as compared to those in controls (120.42 mg/dl, 23.78 mg/dl,167.54 mg/dl respectively).The triglyceride level raised significantly from fasting to postprandial with a mean difference of 16.92 mg/dl in controls and it raised significantly from fasting to postprandial with a mean difference of 65.1 mg/Dl (P = 0.0001). VLDL levels increased significantly from fasting to postprandial (mean difference: 12.48 mg/dl, P <0.000) in IHD patients and it increased by 2.61 mg/dl in control. The levels of total cholesterol (mean difference 12.27mg/dl), HDL (4.62mg/dl) and LDL (20.41mg/dl) decreased from fasting to postprandial in IHD patients. Similarly it decreased by 2.61mg/dl, 2.11mg/dl and 4.01mg/dl in controls respectively.

Key Word: lipid profile in IHD.

 

INTRODUCTION

Ischemic heart disease is a condition in which there is an inadequate supply of blood and oxygen to a portion of the myocardium resulting from imbalance between myocardial oxygen supply and demand.1 In more than 90% of cases, the cause of myocardial ischemia is reduced blood flow due to obstructive atherosclerotic lesions in the coronary arteries, thus IHD is often termed coronary artery disease (CAD) or Coronary Heart Disease (CHD).2 Cardiovascular diseases especially coronary heart diseases (CHD) are epidemic in India. The Registrar General of India reported that CHD led to 17% of total deaths and 26% of adult deaths in 2001-2003, which increased to 23% of total and 32% of adult deaths in 2010-2013. 3 The World Health Organization (WHO) and Global Burden of Disease Study also have highlighted increasing trends in years of life lost (YLLs) and disability adjusted life years (DALYs) from CHD in India. 4 Urbanization in countries mainly South Asian countries, especially India and the Middle East, with increasing economies and growing middle class, elements of the energy-rich Western diet are being adopted. As a result, the prevalence of risk factors for IHD and the prevalence of IHD itself are both increasing rapidly. Risk factors for IHD included non modifiable risk factors like age, gender, family history and modifiable risk factors like Elevated blood cholesterol. High triglyceride (TG) with low HDL, Hypertension, smoking, Diabetes mellitus, unhealthy diet, obesity, physical inactivity, excessive alcohol and stress. 5-11 Diet rich in saturated fats result in increased serum cholesterol. Body accumulates too much of cholesterol it will deposit in the walls of arteries, which become damaged and may become blocked. LDL cholesterol is deposited in the walls of arteries and causes atherosclerosis. Present study was conducted to compare the lipid profile of patients with normal healthy individuals.

 

MATERIAL AND METHODS

 Present study was a case control study carried out in department of Medicine at a tertiary health care centre. Study population was patients diagnosed as Ischaemic Heart Disease patients and healthy controls. Inclusion criteria: 1. Patients diagnosed with IHD based on history, physical examination and investigations 2. Patients above 30 years 3. Healthy controls matched with cases

Exclusion criteria: 1. Patients below 30 years 2. Unstable IHD patients with deranged vital parameters like altered sensorium, fever, tachycardia or bradycardia, hypotension. 3. Hemodynamically unstable patients 4. Patients with cardiomyopathies, rheumatic heart disease and congenital heart disease  The study was approved by the ethical committee of the institute. A valid written consent was taken from patients and controls after explaining study to them. Study was carried out in two groups. First group consisted of 100 healthy individuals without IHD and risk factors for IHD and were considered as controls, second group consisted of 150 patients diagnosed as having IHD. Both the groups are matched with various variables like age, sex. Data was collected with pretested questionnaire. Data included demographic characters, clinical history (significant past or family history) of the patients. A through clinical examination was done for all patients. for confirmation of diagnosis of ischaemic heart disease all patients underwent ECG and 2 D echo of selected patients.

For assessment of lipid profile, blood samples were taken from all patients. Venous blood sample was collected after an overnight fast of 8-12 hours. Postprandial sample was collected 2 hours after meal. Blood cholesterol, triglyceride, high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, very low density lipoprotein (VLDL) cholesterol were estimated in both cases and controls. cases and controls were also evaluated with routine haemogram and biochemical studies like random blood sugar level, liver function test and kidney function test. Data was analysed with software IBM SPSS version 21.0 and MS Excel sheet and by using percentage, chi square, and Student’s t test for proportion. P value < 0.05 was considered as significant.

Given Study is ethical approved by ethical committee of Institution.

 

RESULTS

Out of 100 patients 59 were males and 41 were females in each group. In our study IHD was found more in males.

Table 1 showed age wise distribution of controls and IHD patients. Majority of the patients and controls were from age group of 51-60 years (33.5%) followed by 61-70 years (27.5%). Patients and controls in the age group of 41-50 years contributed 22.5% of all study population. 10.5% study population was above 70 years and 6% was below 40 years.

Among the IHD patients 50% were diagnosed with stable angina and 48% were diagnosed to have myocardial infarction. Only 2 patients had unstable angina. Table 3 shows comparison of lipid profile in controls and cases. In our study mean value of TC in healthy controls was 167.54 mg/dl in fasting state, 164.93 mg/dl in postprandial state and in IHD cases was 187.50 mg/dl in fasting state, 175.23mg/dl in postprandial state. Mean for TG in healthy controls was 120.42 mg/dl in fasting state, 137.34 mg/dl in postprandial state and in IHD cases was 170.65 mg/dl in fasting state, 235.75 mg/dl in postprandial state. Mean for HDL in healthy controls was 41.65 mg/dl in fasting state, 39.54 mg/dl in postprandial state and in IHD cases was 42.41 mg/dl in fasting state, 37.78 mg/dl in postprandial state. Mean for LDL in healthy controls was 104.30 mg/dl in fasting state, 100.29 mg/dl in postprandial state and in IHD cases was 113.47 mg/dl in fasting state, 93.07 mg/dl in postprandial state. Mean for VLDL in healthy controls was 23.78 mg/dl 1 in fasting state, 27.23 mg/dl in postprandial state and in IHD cases was 34.64 mg/dl in fasting state, 47.12 mg/dl in postprandial state. In our study Fasting levels of triglycerides (170.65 mg/dl), serum VLDL(34.64 mg/dl) and total cholesterol(187.5 mg/dl) in patients of IHD are significantly higher as compared to those in controls (120.42 mg/dl, 23.78 mg/dl,167.54 mg/dl respectively) difference between them is statistically significant (p < 0.001). Fasting serum HDL in IHD patients(42.41mg/dl) is slightly more as compared to that in controls(41.65 mg/dl) but statistically not significant. Serum LDL is increased significantly in IHD patients (113.47 mg/dl) as compared to controls 104.30 mg/dl) in fasting state. The triglyceride level raised significantly from fasting to postprandial with a mean difference of 16.92 mg/dl in controls and it raised significantly from fasting to postprandial with a mean difference of 65.1 mg/Dl (P = 0.0001). VLDL levels increased significantly from fasting to postprandial (mean difference: 12.48 mg/dl, P <0.000) in IHD patients and it increased by 2.61 mg/dl in control. The levels of total cholesterol (mean difference 12.27mg/dl), HDL (4.62mg/dl) and LDL (20.41mg/dl) decreased from fasting to postprandial in IHD patients. Similarly it decreased by 2.61mg/dl, 2.11mg/dl and 4.01mg/dl in controls respectively. (table4 and 5) Postprandially, TG levels in IHD patients are found to be raised significantly as compared to controls (p < 0.05) and fasting state (p < 0.001). Total cholesterol is high postprandially as compared to controls (p < 0.001) but decreased as compared to fasting in both controls (p > 0.05) and study group (p < 0.001).


 

Table 1: Distribution of controls and cases according to age group

Sr no

Age group (years)

Control group

Cases

Total

1

31-40

07

05

12(6%)

2

41-50

22

23

45(22.5%)

3

51-60

35

32

67(33.5%)

4

61-70

26

29

55(27.5%)

5

>70

10

11

21(10.5%)

 

Total

100

100

200(100%)

 

Table 2: Distribution of cases according to type of IHD

Sr no

Type of IHD

No of patients

Percentage

1

Stable angina

50

50%

2

Unstable angina

02

2%

3

Myocardial infraction

48

48%

 

Total

100

100%

 

Table 3: comparison of lipid profile in controls and IHD patients

 

TC

TG

HDL

LDL

VLDL

Controls

IHD

Controls

IHD

Controls

IHD

Controls

IHD

Controls

IHD

F(mean)mg/dl

167.54

187.50

120.42

170.65

41.65

42.41

104.30

113.47

23.78

34.64

PP(mea)mg/dl

164.93

175.23

137.34

235.75

39.54

37.78

100.29

93.07

27.23

47.12

 

Table 4: Fasting and post prandial lipid profile in controls

Lipid profile

Fasting

Postprandial

Mean difference

P value

TC

167.54

164.93

2.61

<0.05

TG

120.42

137.34

-16.92

<0.05

HDL

41.65

39.54

2.11

<0.05

LDL

104.30

100.29

4.01

<0.05

VLDL

23.78

27.23

-3.45

<0.05

 

Table 5: Fasting and post prandial lipid profile in IHD cases

Lipid profile

Fasting

Postprandial

Mean difference

P value

TC

187.5

175.23

12.27

<0.0001

TG

170.65

235.75

-65.1

<0.0001

HDL

42.41

37.79

4.62

<0.0001

LDL

113.47

93.06

20.41

<0.0001

VLDL

34.64

47.12

-12.48

<0.0001

 


DISCUSSION

Out of 100 patients 59 were males and 41 were females in each group. In our study IHD was found more in males. These findings were consistent with the study done by Vakil et al., of the 5615 cases of ischemic heart disease, 78.8% were male and 21.2% female, the sex ratio being 3.7 to 1 for the entire series.12Similar findings were observed in a study by Haque et al. in Malaysia. The prevalence of male CHD patient was twice as high as women, 110(69%) and 50(31%) respectively in this study.13 It was similar to the observation of Ferduos et al., where in cases 31 were males and 19 were females and in controls 28 were males and 22 were females.14 In our study, majority of the patients and controls were from age group of 51-60 years (33.5%) followed by 61-70 years (27.5%). Similar to our study, a study by Vakil et al. found that the average age was 46.6 yrs. 54.9% cases were between the ages of 41-60 yrs.12 Similar findings were seen in Mahalle N et al. where Mean age was 60.9 ± 12.4 years, and range was 25-92 years. 15 In contrast to our study Haque et al. found that majority of patients (35%) belonged to 60-69 yrs age group followed by 70-79 yrs age group (34.2%).13 In our study, The triglyceride level raised significantly from fasting to postprandial with a mean difference of 16.92 mg/dl in controls and it raised significantly from fasting to postprandial with a mean difference of 65.1 mg/Dl (P = 0.0001). VLDL levels increased significantly from fasting to postprandial (mean difference: 12.48 mg/dl, P <0.000) in IHD patients and it increased by 2.61 mg/dl in control. The levels of total cholesterol (mean difference 12.27mg/dl), HDL (4.62mg/dl) and LDL (20.41mg/dl) decreased from fasting to postprandial in IHD patients. Similarly it decreased by 2.61mg/dl, 2.11mg/dl and 4.01mg/dl in controls respectively. Similar results were observed in Samson et al., the triglyceride level showed a significant rise from fasting to 2 hours after breakfast with a mean difference of 23.86 mg/dl (P =0.012). VLDL levels showed a similar pattern. Levels increased significantly from fasting to 2h after breakfast (mean difference: 4.49mg/dl, P = 0.007). 16 In our study Fasting levels of triglycerides (170.65 mg/dl), serum VLDL(34.64 mg/dl) and total cholesterol(187.5 mg/dl) in patients of IHD are significantly higher as compared to those in controls (120.42 mg/dl, 23.78 mg/dl,167.54 mg/dl respectively) difference between them is statistically significant (p < 0.001). Similar findings were observed in Shankar et al. where Fasting serum triglycerides, serum VLDL, serum LDL and total cholesterol were increased as compared to controls. And in contrast to our study serum HDL level was decreased in cases. 17 Similarly Ferduos et al. showed that mean (±SD) of TC, TG, LDL-C were significantly higher in cases than that of controls and mean (±SD) HDL-C was significantly lower in cases than that of controls. 14

 

CONCLUSION

The patients with ischemic heart disease are associated with significantly higher levels of serum TC, TG and LDL-C. Postprandial hypertriglyceridemia may be an independent risk factor for atherosclerosis in ischemic heart disease patients.

 

REFERENCES

  1. Antman EM, Loscalzo J.Ischemic Heart Disease. In TR Haarrison. Harrison's Principles of Internal Medicine.19th ed. United States of America: McGraw Hill; 2008.p.1578-80.
  2. Robbins SL, Cotran RS. Hemodynamic Disorders, Thromboembolic Disease, and Shock. In: Kumar V, Abbas K, Fausto N, Aster J, Perkin J, editors. Pathologic basis of disease. 9th ed. Philadelphia: Elsevier; 2015. p.113-34.
  3. Gupta R, Mohan I, Narula J. Trends in Coronary Heart Disease Epidemiology in India. Annals of Global Health 2016; 82(2):307-15.
  4. Bhardwaj R, Kandoria A, Sharma R. Myocardial infarction in young adults-risk factors and pattern of coronary artery involvement. Niger Med J 2014; 55(1):44–7.
  5. Guideline for Lipid Testing in Adults. (CLP017): Community laboratory guidelines. 2013
  6. Dorobantu M, Onciul S, Tautu OF, Cenko E. Hypertension and Ischemic Heart Disease in Women. Curr Pharm Des. 2016; 22(25):3885-92.
  7.  Boudi FB. Risk Factors for Coronary Artery Disease: Practice Essentials, Risk. The Heart ORG Medspace, 2014.
  8. Subramani KS, Kolhari VB, Manjunath CN. Familial hypercholesterolaemia presenting with coronary artery disease in a young patient. BMJ.2013
  9. Hayashi T, Kawashima S, Itoh H, Yamada N, Sone H, Watanabe H et al.. Low HDL Cholesterol Is Associated With the Risk of Stroke in Elderly Diabetic Individuals. Diabetes Care. 2009; 32(7):1221-3.
  10. Harchaoui KE, Visser ME, Kastelein JJ, Stroes ES, Dallinga-thie GM. Triglycerides and Cardiovascular Risk. Curr Cardiol Rev 2009; 5 (3):216–22.
  11. Basak RC, Chatterjee M, Tautu PS. An overview on management of diabetic dyslipidemia. J. Diabetes Endocrinol. 2013; 4(3):27-36.
  12. Vakil RJ, Ischaemic Heart Disease in India. Br Heart J. 1963; 25(3):283–90.
  13. Haque AE, Yusoff FB, Ariffin MH, Hamid Mf, Hashim Sr, Haque M. Lipid Profile of the Coronary Heart Disease (CHD) Patients Admitted in a Hospital in Malaysia, JAPS 2016; 6(5):137-42.
  14. Ferduos BA, Sultana N, Ahmed S, Khan EH, Sultana S, Parvin T. Serum Lipid Profile in Ischemic Heart Disease: A Cross-Sectional Analytical Study. Bangladesh J Med Biochem 2014; 7(1):14-6.
  15. Mahalle N, Garg MK, Naik SS, Kulkarni Mv. Association of metabolic syndrome with severity of coronary artery disease, Indian J Endocrinol Metab. 2014; 18(5):708–14.
  16. Samson CE, Galia AL, Llave KI, Zacarias Mb, Mercado-asis Lb. Postprandial Peaking and Plateauing of Triglycerides and VLDL in Patients with Underlying Cardiovascular Diseases Despite Treatment. Int J Endocrinol Metab. 2012; 10(4):587-93.
  17. Shankar V, Kaur H, Dahiya K, Gupta MS. Comparison of Fasting and Postprandial Lipid Profile in Patients of Coronary Heart Disease. Bombay Hospital Journal 2008; 50(3):445-9.




 
















 



 

Policy for Articles with Open Access:

Authors who publish with MedPulse International Journal of Community Medicine (Print ISSN: 2579-0862) (Online ISSN: 2636-4743) agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.